Latest filing published 06 Jun 2024 for Marksans Pharma Limited, €99k.
Filing timeline
BuySaleSandra Saldanha: trading record in brief
This profile gathers the share dealings of Sandra Saldanha in Marksans Pharma Limited. The record holds 4 filings, for trades running from 27 February 2023 to 5 June 2024.
Purchases make up the whole of the open-market record (4 purchases, €341k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2024: 2 purchases and no sales on the market.
The median purchase comes to €87k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 6 June 2024 came the latest disclosure, an open-market purchase for €99k in Marksans Pharma Limited. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sandra Saldanha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 63,276 shares@ ₹141.482128.9% of flowEquity SharesSEBI:dfed11931fd014b6fe3f87a85ccfcb28c46c388dCanonical exit: 3 Sept 2024 (T+90)
- 47,000 shares@ ₹146.007222.2% of flowEquity SharesSEBI:3a0b28735ed78ab505161496a5f7e7e83147d053Canonical exit: 1 Sept 2024 (T+90)
- 145,000 shares@ ₹66.6932.1% of flowEquity SharesSEBI:03115b70548a4d8d7e43c232df60d3b9b4bbd022Canonical exit: 12 Jun 2023 (T+90)
- 75,000 shares@ ₹67.460316.8% of flowEquity SharesSEBI:60104fd025db59c7aa8a27ffc42a73be37440538Canonical exit: 28 May 2023 (T+90)
4 of 4 declarations